Personalized medicine in oncology: ASCO recommend to test all patients with invasive breast cancer for HER2 status
The American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) issued a joint, updated guideline aimed at improving the accuracy...
Read More